Gene editing analysis
Simple. Reliable. Proven.
Citations
Users
Accuracy vs NGS
Vertex Pharmaceuticals chose TIDE over NGS to evaluate the on-targeting editing frequency and potency of the one-time therapy for sickle cell disease and beta-thalassemia.
NGS is a multistep, resource-intensive process unsuitable for multiple iterations and lot-release QC assays, whereas TIDE is a fast and reliable way to measure cell integrity and editing efficiency, delivering substantial time and money saving.
TIDE is the tool of choice to simply, quickly and accurately assess DNA integrity, whether you edit the genome of mammalian cells, plant protoplasts or produce large batches of nucleic acids such as plasmids. We develop specific workflows to measure genomic contamination, copy number alteration, off-target detection and provide evidence at the DNA sequence level.
TIDE GxP is more than a scientific tool. It is a regulation-compliant solution that simplifies critical assays and minimizes the risk that regulatory agencies will ask for proof of validation.
TIDE (Tracking of Indels by DEcomposition) reads a standard Sanger trace from an edited cell population and reconstructs the spectrum of insertions and deletions produced by the edit. It returns editing efficiency and indel composition without worring about sequencing depth, library preparation or bioinformatics support.
What it measures
Overall editing efficiency, size and frequency of every indel present in the edited sample.
What it needs
A single Sanger sequencing reaction of a PCR amplicon and the guide RNA sequence.
Who uses it
1000s of Discovery teams in biotech, pharma and academia; CDMOs and regulated manufacturing teams.
For the full mechanism behind the analysis, see our technology.

Start with TIDE in Discovery. Keep the same method through development. Submit with it at release.
Start with TIDE in Discovery to quantify your edits quickly from Sanger data.
Keep the same method as your program matures, with no need to switch assays.
Submit with it at release, using TIDE GxP with full validation support.
Trusted by researchers and manufacturing teams at
1000+ organizations worldwide
Free to use app for non-profit organization, free to try for everyone else. Upload your Sanger trace files and get results in seconds. No installation needed.
Start TIDEA faster, simpler path from genome editing to answer — without sacrificing accuracy or compliance.
TIDE estimates your genome engineering success from a single Sanger sequencing reaction, and it is 99% as accurate as NGS. All you need is a PCR product.
The same input gives the same result, whoever runs it and wherever it runs. That consistency is what makes a method defensible in review, transfer and routine release.
Our GxP software is a 21 CFR Part 11 compliant alternative to NGS to help you de-risk any communication with the regulatory authority.
With 3,100+ citations of the original paper and over 100,000 unique users on the public platform – TIDE is the most trusted editing analysis tool in the scientific community.

Brinkman EK, Chen T, Amendola M, van Steensel B. Easy quantitative assessment of genome editing by sequence trace decomposition. Nucleic Acids Research, 42(22), e168 (2014).
You can use any editing technology (CRISPR/Cas9, TALEN or ZFN) to modify your favorite target.
Extract DNA from your population of edited organisms, PCR amplify the region you edited and perform capillary sequencing of the PCR product. Most providers have a one-day turnaround service.
Upload .ab1 trace files and guide RNA sequence into the TIDE web tool and hit analyze — no bioinformatics expertise required. Within seconds you get accurate editing efficiency estimates in addition to qualitative and quantitative information about the whole indel spectrum.
We are the audit-ready provider of TIDE GxP, a software fit for mission-critical use in pharmaceutical development and production, in compliance with GxP and GAMP5 industry standards. It gives you a safe, defensible and reproducible assay readout.
Ideal for release testing of each patient batch in personalized gene editing therapies: quick, cost-effective and simple to run. Both Discovery and GxP licenses can be installed on-premises, on your own IT infrastructure.
Community
TIDE is used daily by hundreds of researchers worldwide. We highlight real experiments and collaborations powered by TIDE — and we would like to feature yours. Tell us about your work and we may publish it for the entire TIDE community to see.
Join leading research institutions and pharmaceutical companies that are already using TIDE for genome-editing success.
No installation. No account required. Used in an FDA-approved cell therapy filing.